BCR-ABL1-dependent acetylation prevented the translocation of p53 to the cytoplasm where it engages in p53/Bax-mediated mitochondrial-dependent apoptosis in response to DNA damage – thus further establishing a link between increased acetylation and CML cell survival. Here, TP53 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.